Your browser doesn't support javascript.
loading
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.
Löwenberg, Bob; Pabst, Thomas; Maertens, Johan; van Norden, Yvette; Biemond, Bart J; Schouten, Harry C; Spertini, Olivier; Vellenga, Edo; Graux, Carlos; Havelange, Violaine; de Greef, Georgine E; de Weerdt, Okke; Legdeur, Marie-Cecile J C; Kuball, Juergen; Kooy, Marinus van Marwijk; Gjertsen, Bjorn T; Jongen-Lavrencic, Mojca; van de Loosdrecht, Arjan A; van Lammeren-Venema, Daniëlle; Hodossy, Beata; Breems, Dimitri A; Chalandon, Yves; Passweg, Jakob; Valk, Peter J M; Manz, Markus G; Ossenkoppele, Gert J.
Afiliação
  • Löwenberg B; Department of Hematology, Erasmus University Medical Center (MC), Rotterdam, The Netherlands.
  • Pabst T; Inselspital, Bern, Switzerland.
  • Maertens J; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium.
  • van Norden Y; HOVON Data Center, Erasmus University MC Cancer Institute, Rotterdam, The Netherlands.
  • Biemond BJ; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
  • Schouten HC; Department of Hematology, University Hospital, Maastricht, The Netherlands.
  • Spertini O; Department of Hematology, University Hospital, Lausanne, Switzerland.
  • Vellenga E; Department of Hematology, University Medical Center, Groningen, The Netherlands.
  • Graux C; UCL Namur (Godinne), Yvoir, Belgium.
  • Havelange V; Department of Hematology, Hôpital St. Luc, Brussels, Belgium.
  • de Greef GE; Department of Hematology, Erasmus University Medical Center (MC), Rotterdam, The Netherlands.
  • de Weerdt O; St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Legdeur MJ; Medisch Spectrum Twente, Enschede, The Netherlands.
  • Kuball J; Department of Hematology, University Medical Center, Utrecht, The Netherlands.
  • Kooy MV; Isala Hospital, Zwolle, The Netherlands.
  • Gjertsen BT; Haukeland University Hospital, Bergen, Norway.
  • Jongen-Lavrencic M; Department of Hematology, Erasmus University Medical Center (MC), Rotterdam, The Netherlands.
  • van de Loosdrecht AA; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
  • van Lammeren-Venema D; Haga Hospital, The Hague, The Netherlands.
  • Hodossy B; Hôpital Citadelle, Liège, Belgium.
  • Breems DA; Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
  • Chalandon Y; Department of Hematology, University Hospital and University of Geneva, Geneva, Switzerland.
  • Passweg J; Department of Hematology, University Hospital, Basel, Switzerland; and.
  • Valk PJ; Department of Hematology, Erasmus University Medical Center (MC), Rotterdam, The Netherlands.
  • Manz MG; Department of Hematology, University Hospital, Zurich, Switzerland.
  • Ossenkoppele GJ; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
Blood ; 129(12): 1636-1645, 2017 Mar 23.
Article em En | MEDLINE | ID: mdl-28049642

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arabinonucleosídeos / Nucleotídeos de Adenina / Leucemia Mieloide Aguda / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arabinonucleosídeos / Nucleotídeos de Adenina / Leucemia Mieloide Aguda / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article